MedPath

Health status and bariatric surgery

Recruiting
Conditions
Morbid Obesity
C18.452
Registration Number
RBR-26chs2g
Lead Sponsor
niversidade Federal do Espírito Santo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Adults >18 years; Body Mass Index>40Kg/m2; Body Mass Index>35Kg/m2 with comorbidities

Exclusion Criteria

Pregnant women; patients using a pacemaker

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To observe an improvement in nutritional status, by reducing body weight (Kg), body mass index (Kg/m2), body fat (% and Kg), changes in fat-free mass (% and Kg), food intake (food survey). It is also expected to observe a reduction in oxidative damage, by measuring the concentrations of substances reactive to thiobarbituric acid, and protein oxidation, and the inflammatory state, by assessing the serum concentration of adipokines (TNF-alpha; interleukin 1, 6, 10). ). It is also expected to observe a reduction in the lipid profile, evaluated by the serum concentrations of triglycerides and total cholesterol and fractions.
Secondary Outcome Measures
NameTimeMethod
To demonstrate the applicability of Fourier Transform Infrared Spectroscopy to evaluate the oxidative and inflammatory status of patients during the treatment of severe obesity. Considering that oxidative stress and the inflammatory state are directly associated with the pathophysiology of numerous diseases and their complications, and the factors that make their analysis impraticable in biochemical routine tests, the scientific information could contribute to the development of methodologies for the use of Fourier Transform Infrared Spectroscopyto monitor the health conditions of individuals in different clinical conditions.
© Copyright 2025. All Rights Reserved by MedPath